A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-Segment Elevation Myocardial Infarction.EXAMINATION Study.
Phase of Trial: Phase III
Latest Information Update: 15 Oct 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms EXAMINATION
- 18 May 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 22 Jul 2014 Planned End Date changed from 1 Jan 2015 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 22 Jul 2014 Planned primary completion date changed from 1 Dec 2014 to 1 May 2015 as reported by ClinicalTrials.gov record.